drugset / Trial / NCT02088970

Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)

NCT02088970 ↗

Terminated 21 enrolled Nantes University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The corneal collagen cross linking is currently used in the treatment of keratoconus but this procedure has also a sterilizing non-specific effect on bacteria and fungus. So the corneal cross linking in association with the antibiotic treatment could result in a reduction of the duration of epithelial complete healing of the cornea.

Timeline

Start
2014-09
Primary completion
2017-04
Completion
2017-04

Outcome

Outcome not reported

Stopped: “Difficulties in reaching the desired number of patients and intermediate analysis leading to discontinuation of the study.”

Drugs

EvaluationDrugModalityDoseRoute
Background Amiklin Unknown — —
Background Amphotericin B Unknown — —
Background Fortum Unknown — —
Background Vancomycin Other / unclassified — —

Indications